Jaguar Health Inc (NASDAQ: JAGX) has experienced a decline in its stock price by -0.24 compared to its previous closing price of 4.11. However, the company has seen a gain of 0.24% in its stock price over the last five trading days. accesswire.com reported 2024-07-18 that Webcast on Tuesday, July 23rd at 8:30 AM Eastern will include updates on Jaguar’s cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea (CTD) and oral mucositis; Click here to register for webcast Jaguar expands Make Cancer Less Shitty (MCLS) patient advocacy program to incorporate select group of MCLS Ambassadors – cancer survivors who understand the realities of cancer and are no longer willing to accept debilitating side effects of cancer treatments as an acceptable trade-off for survival Cancer patients with diarrhea are 40% more likely to discontinue their therapy; oral mucositis affects up to 40% of patients undergoing chemotherapy and approximately 90% of those receiving chemoradiation for head and neck cancers, with more than one-third of patients discontinuing cancer treatment because of the condition SAN FRANCISCO, CA / ACCESSWIRE / July 18, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”) today announced that it will hold an investor webcast on Tuesday, July 23, 2024 at 8:30 AM Eastern to review results for the company’s pivotal phase 3 OnTarget trial of crofelemer for prophylaxis of diarrhea in adult cancer patients with solid tumors receiving targeted therapy, with or without standard chemotherapy. A press release announcing the results will be issued that morning, prior to the webcast.
Is It Worth Investing in Jaguar Health Inc (NASDAQ: JAGX) Right Now?
The 36-month beta value for JAGX is at 0.89. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for JAGX is 4.18M, and currently, shorts hold a 7.49% of that float. The average trading volume for JAGX on July 18, 2024 was 817.18K shares.
JAGX’s Market Performance
JAGX stock saw an increase of 0.24% in the past week, with a monthly gain of 8.47% and a quarterly increase of -58.56%. The volatility ratio for the week is 5.45%, and the volatility levels for the last 30 days are 7.33% for Jaguar Health Inc (JAGX). The simple moving average for the past 20 days is 6.33% for JAGX’s stock, with a -59.11% simple moving average for the past 200 days.
Analysts’ Opinion of JAGX
Many brokerage firms have already submitted their reports for JAGX stocks, with Cantor Fitzgerald repeating the rating for JAGX by listing it as a “Overweight.” The predicted price for JAGX in the upcoming period, according to Cantor Fitzgerald is $5 based on the research report published on July 07, 2021 of the previous year 2021.
Rodman & Renshaw, on the other hand, stated in their research note that they expect to see JAGX reach a price target of $2. The rating they have provided for JAGX stocks is “Buy” according to the report published on July 11th, 2017.
JAGX Trading at -40.30% from the 50-Day Moving Average
After a stumble in the market that brought JAGX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.18% of loss for the given period.
Volatility was left at 7.33%, however, over the last 30 days, the volatility rate increased by 5.45%, as shares surge +6.52% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -78.10% lower at present.
During the last 5 trading sessions, JAGX rose by +1.83%, which changed the moving average for the period of 200-days by -73.30% in comparison to the 20-day moving average, which settled at $3.87. In addition, Jaguar Health Inc saw -54.87% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for JAGX
Current profitability levels for the company are sitting at:
- -3.18 for the present operating margin
- 0.67 for the gross margin
The net margin for Jaguar Health Inc stands at -3.78. The total capital return value is set at -0.86. Equity return is now at value -351.06, with -68.24 for asset returns.
Based on Jaguar Health Inc (JAGX), the company’s capital structure generated 0.69 points at debt to capital in total, while cash flow to debt ratio is standing at -0.93. The debt to equity ratio resting at 2.25. The interest coverage ratio of the stock is -6.71.
Currently, EBITDA for the company is -31.53 million with net debt to EBITDA at -0.73. When we switch over and look at the enterprise to sales, we see a ratio of 4.12. The receivables turnover for the company is 5.92for trailing twelve months and the total asset turnover is 0.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.89.
Conclusion
In conclusion, Jaguar Health Inc (JAGX) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
